Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
49,768,891
-
Total 13F shares
-
44,006,668
-
Share change
-
+1,499,933
-
Total reported value
-
$2,449,179,355
-
Put/Call ratio
-
19%
-
Price per share
-
$55.67
-
Number of holders
-
190
-
Value change
-
+$92,761,072
-
Number of buys
-
98
-
Number of sells
-
75
Institutional Holders of AtriCure, Inc. - Common Shares (ATRC) as of Q4 2020
As of 31 Dec 2020,
AtriCure, Inc. - Common Shares (ATRC) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,006,668 shares.
The largest 10 holders included
BlackRock Inc., FRED ALGER MANAGEMENT, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., Champlain Investment Partners, LLC, FMR LLC, TimesSquare Capital Management, LLC, ORBIMED ADVISORS LLC, and CREDIT SUISSE AG/.
This page lists
190
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.